Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Research Focus Areas Investigations into copper transport and biological copper homeostasis Studies of dermal fibroblast collagen and elastin synthesis in cell culture Examination of wound-healing pathways in rodent skin models Antioxidant and superoxide-dismutase mimetic activity in in-vitro assays Hair-follicle and dermal-papilla cell research Quality & Verification Synthesized via solid-phase peptide synthesis (SPPS) in an ISO-certified facility 99% purity verified by reverse-phase HPLC Cu content confirmed by atomic absorption spectroscopy or ICP-MS Independent third-party Certificate of Analysis available on request Sequence: Gly-His-Lys (with Cu coordination) Storage & Handling Store lyophilized vials at 20C for long-term stability (protected from light) Once reconstituted, store at 28C and use within 2830 days Avoid repeated freeze-thaw cycles Sealed under nitrogen and shipped in insulated packaging Preclinical Research Summary GHK-Cu is the copper(II) complex of the endogenous human tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys)
To properly upkeep, an individual should receive regular injections for several months
1, 2a, 3a, 4a, and 5a are created with BioRender.com
Mechanisms involved in the therapeutic effects of Paeonia lactiflora Pallas in rheumatoid arthritis
The incorporation of positively charged l-Ara4N (Fig.3) neutralizes the native negative charge on lipid A, thereby inhibiting the binding of cationic antimicrobial peptides, such as PMs [50]
Some studies suggest that higher doses, up to 2,000 mg per day , may be beneficial for specific conditions, such as chronic illness or high oxidative stress
